(Q35005965)

5 August 2017

1 reference

title

HLA-B27 and the pathogenesis of spondyloarthritis (English)

1 reference

5 August 2017

Ramos M

1

1 reference

5 August 2017

López de Castro JA

series ordinal

2

1 reference

5 August 2017

language of work or name

1 reference

1 September 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

60

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

191-205

1 reference

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Guilt by association: HLA-B27 and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The role of HLA-B27 in spondyloarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Incidence of RA in people with persistently raised RF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The HLA-B*2709 subtype confers susceptibility to spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Diversity is demonstrated in class I HLA-A and HLA-B alleles in cameroon, africa: Description of HLA-A*03012, *2612, *3006 and HLA-B*1403, *4016, *4703

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Large sharing of T-cell epitopes and natural ligands between HLA-B27 subtypes (B*2702 and B*2705) associated with spondyloarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Structural Comparison of Allogeneic and Syngeneic T Cell Receptor–Peptide-Major Histocompatibility Complex Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The recognition of HLA-B27 by human CD4(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Viral subversion of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Disparate binding of chaperone proteins by HLA-A subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Identification of self peptides bound to purified HLA-B27

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Jekyll and Hyde: the transformation of HLA-B27

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

New insights regarding HLA-B27 diversity in the Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

Ankylosing spondylitis and HL-A 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Reiter's disease and HL-A 27.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Possible protective role of HLA-B*2706 for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

The HLA-B*2709 subtype in a patient with undifferentiated spondarthritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

B27-negative HLA-BW16 in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

HLA-B27 (B*2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Long-range effects in protein--ligand interactions mediate peptide specificity in the human major histocompatibilty antigen HLA-B27 (B*2701).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

The naturally occurring polymorphism Asp116-->His116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Dissociation of beta 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

Enterobacterial infection modulates major histocompatibility complex class I expression on mononuclear cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.600301.X

7 January 2021

10.1034/J.1399-0039.2002.600301.X

Identifiers

DOI

1 reference

5 August 2017

1 reference